Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children

References

Page 1

	Year	Citations
Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency Syndrome Robert S. Klein, Carol Harris, Catherine B. Small, New England Journal of Medicine Primary ImmunodeficiencyMedicineClinical EpidemiologyImmunologyVaginitis	1984	862
Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals Derek J. Sullivan, Ken Haynes, Désirée E. Bennett, Microbiology	1995	771
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species Frank C. Odds, R Bernaerts Journal of Clinical Microbiology BiologyFungal DiversityYeast IsolatesDiagnostic MycologyAntifungal Agent	1994	623
Incidence of Opportunistic and Other Infections in HIV-Infected Children in the HAART Era Philimon Gona, Russell B. Van Dyke, Paige L. Williams, JAMA	2006	282
The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study Anwar R. Tappuni, Garry J.P. Fleming Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology Treatment And PreventionOral HygieneAntiviral TherapyChronic Viral InfectionOral Manifestations	2001	161
Role of Protease Inhibitors in Preventing Recurrent Oral Candidosis in Patients With HIV Infection: A Prospective Case-Control Study Roberto Cauda, Evelina Tacconelli, Mario Tumbarello, JAIDS Journal of Acquired Immune Deficiency Syndromes	1999	134
Incidence of Oral Lesions in HIV-1-infected Women: Reduction with HAART Deborah Greenspan, Stephen J. Gange, Joan Phelan, Journal of Dental Research Hiv-1-infected WomenClinical MycologyDermatologySocial SciencesHuman Retrovirus	2004	132
Effects of the Human Immunodeficiency Virus (HIV) Proteinase Inhibitors Saquinavir and Indinavir on In Vitro Activities of Secreted Aspartyl Proteinases of <i>Candida albicans</i> Isolates from HIV-Infected Patients Hans Christian Körting, Martin Schaller, Gabriele C. Eder, Antimicrobial Agents and Chemotherapy Proteinase Inhibitors SaquinavirHiv Proteinase InhibitorsSecreted Aspartyl ProteinasesMedicineHuman Retrovirus	1999	131
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases Margarete Borg‐von Zepelin, Ingo Meyer, Reiner Thomssen, Journal of Investigative Dermatology Antifungal AgentImmunologyYeastMicrobiologyAntiviral Drug	1999	126
Secretor status, candidal carriage and candidal infection in patients with diabetes mellitus P.‐J. Lamey, A. Darwaza, BM Fisher, Journal of Oral Pathology and Medicine	1988	91

Page 1